Added to YB: 2026-02-11
Pitch date: 2026-02-09
HIMS [neutral]
Hims & Hers Health, Inc.
+8.72%
current return
Author Info
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$18.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
special_situation
HIMS: Napoleon Watches Moscow Burn
HIMS (update - short): Analysts warned CEO Andrew Dudum was pushing compounding GLP-1 loophole too far. After launching knock-off Wegovy pill with no clinical data, FDA specifically called out HIMS & HHS referred company to DOJ for potential criminal violations of Federal Food, Drug & Cosmetic Act. Stock -15% AH.
Read full article (4 min)